Plasma phospholipid fatty acid pattern in severe liver disease

Area of Science:

• Biochemistry
• Clinical Nutrition
• Hepatology

Background:

• Acute liver failure necessitates liver regeneration, potentially increasing essential fatty acid (EFA) consumption.
• Current nutritional support primarily relies on glucose infusion, raising concerns about EFA deficiency development in these patients.

Purpose of the Study:

• To investigate plasma phospholipid fatty acid composition in patients with acute liver failure (ALF) and other liver conditions.
• To assess the impact of glucose infusion on EFA levels in healthy individuals.

Main Methods:

• Analyzed plasma phospholipid fatty acid profiles in healthy controls, patients with ALF, stable cirrhosis, and acute-on-chronic liver disease with hepatic encephalopathy.
• Evaluated the effect of a 2-day fat-free diet followed by glucose infusion in healthy controls.

Main Results:

• Patients with ALF and acute-on-chronic liver disease exhibited significantly higher non-essential/essential fatty acid ratios compared to healthy controls and cirrhosis patients.
• Low linoleic acid and high oleic acid levels were observed in ALF and acute-on-chronic liver disease groups.
• Eicosatrienoic acid, an indicator of EFA deficiency, was frequently detected across all patient groups, particularly in those with severe liver dysfunction.

Conclusions:

• Acute severe liver dysfunction is linked to plasma phospholipid fatty acid alterations suggestive of essential fatty acid deficiency.
• Standard glucose-based nutritional support may not adequately address EFA requirements in patients with acute liver failure.